Univest
Univest
  • Markets

Novartis India (NOVARTIND) Share Price Rises 8.85% Today to Rs 2,142

  • September 8, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Novartis India Share Price
Novartis India Ltd. (NOVARTIND) share price rose to Rs 2,142 today, up 8.85% from the previous close. Market cap was Rs 4,858.78 crore.

Novartis India Share Price is in focus after the stock rose 8.85% to Rs 2,142, taking the company’s market capitalisation to Rs 4,858.78 Cr. The move places Novartis India Share Price among the notable gainers in today’s market, with the latest Univest figures confirming a strong intraday price rise. Univest figures confirm the price action, but they do not point to a specific company trigger.

For readers tracking Novartis India Share Price Today, the event matters because the stock moved well above the previous close while also staying near the upper end of the day’s range. In this Novartis India Stock News note, the focus is on price action, valuation, and sector comparison rather than speculation. Univest data shows the stock’s current move alongside its trading range and fundamental ratios, which helps frame whether the share price rise changes the discussion around Novartis India Share Price, Novartis India Stock Analysis and Novartis India Fundamental Analysis. Investors watching Novartis India Share Price can next monitor whether the current level holds against the day’s range and how the valuation compares with listed trading peers.

Table of Contents

Toggle
  • Novartis India Share Price Today: Price Action Analysis
  • Novartis India Ltd. (NOVARTIND) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching Novartis India
  • About Novartis India
  • Frequently Asked Questions
    • Why is Novartis India Share Price rising today?
    • What is Novartis India Share Price today?
    • What does Novartis India Stock News show intraday?
    • How does Novartis India Share Price compare with the sector benchmark?
    • What are the key fundamentals behind Novartis India Share Price?
    • How does Novartis India compare with peers?
    • Where can I track Novartis India Share Price live?
  • Track Novartis India Share Price on Univest

Novartis India Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 2,142
Previous Close Rs 1,967.85
Today's Move Rs 174.15 (+8.85%)
Open Rs 2,006
High Rs 2,164.6
Low Rs 2,006
Market Capitalisation Rs 4,858.78 crore
Market Cap Category Small Cap

Novartis India Ltd. (NOVARTIND) rose to Rs 2,142 from the previous close of Rs 1,967.85, a move of Rs 174.15 or 8.85%. The stock opened at Rs 2,006, reached a high of Rs 2,164.6, recorded a low of Rs 2,006.

Novartis India Share Price rose sharply today, with the stock trading at Rs 2,142 after opening at Rs 2,006 and touching an intraday high of Rs 2,164.60. The day low was Rs 2,006, so the share price rise stayed firmly within that range while keeping the stock well above the previous close of Rs 1,967.85.

In percentage terms, the move translated into an advance of Rs 174.15 or 8.85% for Novartis India Share Price Today. That makes it a clear price rise rather than a marginal drift, and it places the stock in the day’s top gainer conversation on the Indian stock market. The latest Univest figures show that the stock’s market capitalisation now stands at Rs 4,858.78 Cr, which provides scale context for the move. For Novartis India Share Price, the key intraday markers are simple: an opening gap-up, a higher trading band, and a price that is close to the day’s peak. Novartis India Share Price, Novartis India Share Price Live and Novartis India Share Price Update remain the relevant terms to follow as the session progresses.

This price action does not, by itself, establish a company-specific reason. Univest figures confirm the price action, but they do not point to a specific company trigger. The next section places Novartis India Share Price in fundamental context.

Novartis India Ltd. (NOVARTIND) Fundamental Analysis

Metric Value
Market Capitalisation Rs 4,858.78 crore
P/E Ratio 49.7x
P/B Ratio 5.72x
ROE 11.63%
ROCE 16.34%
EPS Rs 39.6
Book Value Per Share Rs 344.28
Dividend Yield 0%

Novartis India Ltd. (NOVARTIND) fundamental metrics show P/E 49.7x, P/B 5.72x, ROE 11.63%, ROCE 16.34%. Taken on their own, these numbers offer context rather than a trading signal.

Novartis India Ltd. has a market capitalisation of Rs 4,858.78 crore and falls in the Small Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 49.7x, P/B at 5.72x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 11.63% and ROCE of 16.34%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 39.6, book value per share of Rs 344.28, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 23.28x, median ROE of 4%, median ROCE of 5.83%. They set out the fundamental picture and are not a rating on the stock.

Sector and Industry Context

Metric Value
Sector Trading
Industry Trading
Benchmark Scope same industry
Company P/E Ratio 49.7x
Benchmark Median P/E 23.28x
Benchmark Average P/E 107.55x
Benchmark P/E Range 0.14x to 7,848.75x
Company P/B Ratio 5.72x
Benchmark Median P/B 1.42x
Company ROE 11.63%
Benchmark Median ROE 4%
Company ROCE 16.34%
Benchmark Median ROCE 5.83%
Company Market Capitalisation Rs 4,858.78 crore
Benchmark Median Market Cap Rs 50.81 crore

Novartis India Ltd. (NOVARTIND) operates in the Trading sector, within the Trading industry.

Novartis India Ltd. (NOVARTIND) has a P/E ratio of 49.7x, which is above the benchmark median of 23.28x, a difference of +113.49%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Novartis India Ltd. (NOVARTIND) has a ROE of 11.63%, which is above the benchmark median of 4%, a difference of +190.75%. Novartis India Ltd. (NOVARTIND) has a ROCE of 16.34%, which is above the benchmark median of 5.83%, a difference of +180.27%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Adani Enterprises Ltd. ADANIENT 3,82,331.87 51.36 4.05 15.07 13.3
Aegis Logistics Ltd. AEGISLOG 49,166.32 39.29 7.45 20.71 19.76
ADITYA INFOTECH LIMITED CPPLUS 46,587.2 97.61 13.25 25.68 29.48
Premier Energies Ltd. PREMIERENE 39,800.2 23.9 8.37 42.6 33.72
Redington Ltd. REDINGTON 31,098.99 18.28 2.93 13.6 18.96

Novartis India Ltd. (NOVARTIND) has a P/E ratio of 49.7x compared with the displayed peer median of 39.29x. The comparison is relative and should not be read as a recommendation. Its ROE of 11.63% compares with a peer median of 20.71% across the companies shown in the table. ROCE stood at 16.34% versus the displayed peer median of 19.76%, providing a capital-efficiency comparison. Novartis India Ltd. (NOVARTIND) has a market capitalisation of Rs 4,858.78 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Novartis India

  • Novartis India Share Price rose 8.85% today and is trading near the day’s high.
  • The stock’s market capitalisation is Rs 4,858.78 Cr, which gives scale to the move.
  • P/E of 49.7 and P/B of 5.72 place Novartis India Share Price at a premium to the benchmark median.
  • ROE of 11.63% and ROCE of 16.34% are above the same-industry benchmark centre.
  • Peer comparison shows Novartis India Share Price sits between lower-priced valuation names and higher-return peers.

About Novartis India

Novartis India Ltd. operates in the Trading sector and the Trading industry. For readers following Novartis India Share Price, the company’s listed profile is best understood through its financial metrics and sector placement rather than through broad labels. The business context in the latest Univest figures is tied to a market capitalisation of Rs 4,858.78 Cr, which places the company within a visible listed peer group.

Novartis India Share Price, Novartis India Stock News and Novartis India Stock Analysis are usually read together because price action and valuation are linked in market discussion. With a P/E of 49.7, P/B of 5.72, ROE of 11.63% and ROCE of 16.34%, the company’s profile suggests a stock that is being assessed on both earnings and asset valuation. EPS at Rs 39.6 and book value at Rs 344.28 add more context for how the market is pricing the business. Dividend yield at 0 also tells readers that the current investment case here is not anchored to a cash yield.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).

Frequently Asked Questions

Why is Novartis India Share Price rising today?

Ans. Novartis India Share Price is rising today because it traded up 8.85% to Rs 2,142. Univest figures confirm the price action, but they do not point to a specific company trigger.

What is Novartis India Share Price today?

Ans. Novartis India Share Price today is Rs 2,142. The stock is up Rs 174.15 from the previous close of Rs 1,967.85, and the latest Univest figures place market cap at Rs 4,858.78 Cr.

What does Novartis India Stock News show intraday?

Ans. Novartis India Stock News shows an intraday rise from an opening price of Rs 2,006 to a high of Rs 2,164.60. The share price stayed within that range while trading above the previous close.

How does Novartis India Share Price compare with the sector benchmark?

Ans. Novartis India Share Price trades at a P/E of 49.7 versus the same-industry median of 23.28, and P/B of 5.72 versus 1.42. ROE and ROCE are also above the benchmark centre.

What are the key fundamentals behind Novartis India Share Price?

Ans. The key fundamentals behind Novartis India Share Price are EPS of Rs 39.6, book value of Rs 344.28, ROE of 11.63% and ROCE of 16.34%. Dividend yield is 0% in the latest Univest figures.

How does Novartis India compare with peers?

Ans. Novartis India Share Price has a P/E below CPPLUS and slightly below Adani Enterprises, but above Redington, Aegis Logistics and Premier Energies. Its ROE is above the sector median, though not the highest among peers.

Where can I track Novartis India Share Price live?

Ans. You can track Novartis India Share Price live on Univest, where current price, market cap, valuation ratios, 52-week levels and company context are brought together for quick monitoring during the trading session.

Track Novartis India Share Price on Univest

Use Novartis India Ltd. (NOVARTIND) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Track Novartis India Share Price on Univest to follow live share price moves, valuation ratios, market capitalisation, 52-week levels and broader market insights in one place. Univest brings together Novartis India Share Price Today, Novartis India Stock News and Novartis India Fundamental Analysis for easy monitoring.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply